Article citationsMore>>

Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Scheiderbauer, J., Machulla, H.J., Dittmann, H., Vonthein, R. and Bares, R. (2006) Is Standardised 18F-FDG Uptake Value an Outcome Predictor in Patients with Stage III Non-Small Cell Lung Cancer? European Journal of Nuclear Medicine and Molecular Imaging, 33, 263-269.
http://dx.doi.org/10.1007/s00259-005-1953-2

has been cited by the following article:

• TITLE: Prognostic Significance of Standardized Uptake Value of PET Scan in Non-Small Cell Lung Cancer

  AUTHORS: A. Alshuhayeb, S. Gilbert, A. J. E. Seely, F. M. Shamji, S. Sundaresan, P. J. Villeneuve, D. E. Maziak

  KEYWORDS: Non Small Cell Lung Cancer, SUV, PET, Prognosis

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.3, March 18, 2016

  ABSTRACT: Background: To determine if the maximum standardized uptake value (SUVmax) of the primary tumor as determined by preoperative (18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) is an independent predictor of overall survival, mediastinal lymph node metastasis, and stage in patients with non-small cell lung cancer (NSCLC). Methods: A retrospective review of 1033 patients with stage I-IV histologically proven NSCLC who had an (18)F-FDG PET done between 2005 and 2011 for staging before receiving therapy was performed. SUVmax of primary NSCLC was measured and correlated with tumor characteristics, lymph node involvement, cancer stage and overall survival. The patients were divided into three groups according to their SUVmax value: group I SUVmax 10. The primary outcome was survival and recurrence rate, compared using Log Rank Test. Results: The median duration of follow up was 675 days (22.5 months). The overall survival at two years for group I was 88%, group II 60% and group III 53%, significantly different among the three groups (p-value